• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Fibrin Sealant in Operative Medicine: Volume 1: Otorhinolaryngology

Fibrin Sealant in Operative Medicine: Volume 1: Otorhinolaryngology

Paperback

Medical Reference

ISBN10: 354016734X
ISBN13: 9783540167341
Publisher: Springer Nature
Published: Aug 1 1986
Pages: 163
Weight: 0.65
Height: 0.38 Width: 6.69 Depth: 9.61
Language: English
Fibrin plays a prominent role in wound healing. It has a hemostatic effect, induces cellular response to wound damage, ' and, by forming strands to build a matrix, assists in neovascularization and fibroblast proliferation. The concept of using clotting substances from human blood for wound manage- ment and to achieve hemostasis in bleeding parenchymatous organs can be traced to 1909, when Bergel [1] reported on the hemostatic effect of fibrin powder. In 1915, Grey [3] employed fibrin to control bleeding in neurosurgical operations of the brain. A year later, Harvey [4] used fibrin patches to stop bleeding from parenchy- matous organs in general surgery. It took more than two decades for this ingenious idea to be rediscovered. In 1940, Young and Medawar [8] reported on experimental nerve anastomosis by sealing. Similarly, Tarlov and Benjamin [7] reunited nerves with plasma clots in 1943. Tarlov improved the results obtained with clot anastomosing of nerves by avoiding tension at the nerve stumps. In 1944, Cronkite et al. [2] reported on an initial series of eight cases in which fibrinogen and thrombin had been used successfully for anchoring skin grafts.

Also in

Medical Reference